View in EDS HTML Full Text PDF Full Text

Baseline metabolic tumor burden on FDG PET/CT scans predicts outcome in advanced NSCLC patients treated with immune checkpoint inhibitors.

Saved in:
Bibliographic Details
Title: Baseline metabolic tumor burden on FDG PET/CT scans predicts outcome in advanced NSCLC patients treated with immune checkpoint inhibitors.
Authors: Seban, Romain-David1 (AUTHOR), Mezquita, Laura2 (AUTHOR), Berenbaum, Arnaud1 (AUTHOR), Dercle, Laurent3 (AUTHOR), Botticella, Angela4 (AUTHOR), Le Pechoux, Cécile4 (AUTHOR), Caramella, Caroline5 (AUTHOR), Deutsch, Eric4,6,7 (AUTHOR), Grimaldi, Serena1 (AUTHOR), Adam, Julien8 (AUTHOR), Ammari, Samy5 (AUTHOR), Planchard, David2 (AUTHOR), Leboulleux, Sophie1 (AUTHOR), Besse, Benjamin2,7 (AUTHOR) Benjamin.BESSE@gustaveroussy.fr
Source: European Journal of Nuclear Medicine & Molecular Imaging. May2020, Vol. 47 Issue 5, p1147-1157. 11p. 2 Diagrams, 3 Charts, 2 Graphs.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:16197070
DOI:10.1007/s00259-019-04615-x